维普期刊资源整合服务平台（V6.5）

66篇 您的检索式：作者名="WASSE H"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	A perspective on the current state of death education显示文摘	Wass H	2004	Death Stud2004，28，4：	1
2	Accumulation of retained nonfunctional arteriovenous grafts correlates with severity of inflammation in asymptomatic ESRD pa- tients 显示文摘	Wasse H Cardarelli F DeStaercke C	2013	Nephrology Dialysis Transplant2013，28，4：	1
3	Angiogenesis in endocrine tumors 显示文摘	TURNER H E HARRIS MELMED S WASS J A	2003	Endocr R ev2003，24，5：	1
4	Arteriovenous fistula use is associated with lower cardiovascular mor?tality c-ompared with catheter use among ESRD patients显示文摘	Wasse H Speckman RA McClellan WM	2008	Semin Di-al2008，21，：	1
5	Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients显示文摘	Wasse H Gillen DL Ball AM	2003	Kidney Int2003，64，4：	1
6	Angiogenesis in prolactinomas : regulation and relationship with tumour behaviour 显示文摘	De la Torte N G Turner H E Wass J A	2005	Pituitary2005，8，1：	1
7	Predictors of central venous catheter use at the initiation of hemodialysis 显示文摘	Wasse H Speckman RA Frankenfield DL	2008	Semin Dial2008，21，4：	1
8	Propane dehydrogenation over molybdenum hydrotalcite catalysts 显示文摘	MITCHELL P C H WASS S A	2002	Applied Catalysis A: General2002，225，12：	1
9	Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis显示文摘	WASSE H HUANG R LONG Q		0，，02：	1
10	Risk factors for upper gastroin-testinal bleeding among end-stage-renal disease patients 显示文摘	Wasse H Gillen DL Ball AM	2003	KidneyInt2003，64，4：	1
11	Antian- giogenic effects of somatostatin analogues 显示文摘	CARCIA- de-la-TORRE N WASS J A TURNER H E	2002	Clin Endocrinol ( Oxf)2002，57，4：	1
12	Propane dehydrogenation over molybdenum hydrotalcite catalysts 显示文摘	Mitchell P C H Wass S A	2002	Applied Catalysis A: General2002，，225：	1
13	Association of ini- tial hemodialysis vascular access with patient-report- ed health status and quality of life显示文摘	Wasse H Kutner N Zhang R	2007	Clin J Am Soe Nephrol2007，2，4：	1
14	Risk factors for upper gastrointestinal bleeding among end-stage-renal disease patients 显示文摘	WASSE H GILLEN D L BALL A M	2003	Kidney Int2003，64，4：	1
15	Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients 显示文摘	Wasse H Gillen D L Ball A M	2003	Kidney Int2003，64，4：	1
16	Predictors of delayed transition from central venous catheter use to permanent vascular access among ESRD patients 显示文摘	WASSE H SPECKMAN R A FRANKENFIELD D L	2007	Am J Kidney Dis2007，49，2：	1
17	Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis 显示文摘	Wasse H Huang R Long Q	2012	Am J Clin Nutr2012，95，2：	1
18	Vascular mapping: does it help to maximize fistulae placement?显示文摘	Niyyar VD Wasse H	2009	Adv Chronic Kidney Dis2009，16，：	1
19	Antiangioganic effects of somatostatin analogues 显示文摘	De la Torre G N Wass J A Turner H E	2002	Clin Endocrinol ( Oxf )2002，57，4：	1
20	Predictors of delayed transition from central venous catheter use to permanent vascular access among ESRD patients显示文摘	Wasse H Speckman RA Frankenfield DL	2007	Am J Kidney Dis2007，49，2：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示